Header image

Sanofi Breakfast Symposium - What next for COPD?  Biomarkers, phenotypes, endotypes and targeted treatment

Monday, March 24, 2025
7:15 AM - 8:15 AM
E2
Sponsored By:
Sanofi

Details

National thought leaders review and discuss the emerging understanding of Chronic Obstructive Pulmonary Disease (COPD) pathophysiology, recognise diverse phenotypes and endotypes that drive disease progression and explore the evolving therapeutic landscape targeting drivers of COPD pathophysiology.


Speaker

Agenda Item Image
Prof Philip Bardin
Professor, Monash Lung Sleep Allergy & Immunology
Monash Lung and Sleep

What next for COPD? Biomarkers, phenotypes, endotypes and targeted treatment

Biography

Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Currently Emeritus Director, Lung & Sleep Medicine, Monash University and Medical Centre, Melbourne. He is recognised for investigation of obstructive lung diseases and his professional activities reflect a career-long commitment to research and medical education.
Agenda Item Image
Dr Sanjay Ramakrishnan
Senior Lecturer
Institute for Respiratory Health

What next for COPD? Biomarkers, phenotypes, endotypes and targeted treatment

Biography

Sanjay Ramakrishnan is a respiratory physician and researcher. His research focus is on asthma and COPD exacerbations, specifically improving biological assessment and biomarker guided treatment of these life threatening events. He completed his medical and specialist training in Australia before undertaking his PhD in the UK. He is now leading his own research group in Perth, Western Australia. His vision is to ensure every patient gets biomarker guided treatment for every exacerbation, in every clinical setting.
Agenda Item Image
Assoc Prof Katrina Tonga
Respiratory & Sleep Physician
Westmead Hospital

What next for COPD? Biomarkers, phenotypes, endotypes and targeted treatment

Biography

Katrina Tonga is a research affiliate at the Woolcock Institute of Medical Research, and staff specialist at Westmead Hospital, Sydney. She holds academic appointments as an Adjunct senior lecturer at St Vincent’s Clinical School, University of New South Wales and Associate Professor at Westmead Clinical School, University of Sydney. She has a research interest in airway physiology, chronic airways and lung disease and early detection of lung disease and maintains active participation in the activities of the Airway Physiology & Imaging Research Group, Woolcock NextGen ECR committee and Thoracic Society of Australia and New Zealand.
loading